1. Effects of different sodium–glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a network meta-analysis
- Author
-
Xiaohua Lan, Huijing Zhu, Yanjie Cao, Yue Hu, Xingman Fan, Kaijie Zhang, and Mengdi Wu
- Subjects
sodium–glucose cotransporter 2 inhibitors ,heart failure ,cardiac structural remodeling ,heart failure with reduced ejection fraction ,heart failure with preserved ejection fraction ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundThis systematic review and meta-analysis aimed to explore the effects of different sodium–glucose cotransporter-2 inhibitors (SGLT2i) on prognosis and cardiac structural remodeling in patients with heart failure (HF).MethodsRelevant studies published up to 20 March 2024 were retrieved from PubMed, EMBASE, Web of Science, and Cochrane Library CNKI, China Biomedical Literature Service, VIP, and WanFang databases. We included randomized controlled trials of different SGLT2i and pooled the prognosis data of patients with HF. We compared the efficacy of different SGLT2i in patients with HF and conducted a sub-analysis based on left ventricular ejection fraction (LVEF).ResultsWe identified 77 randomized controlled trials involving 43,561 patients. The results showed that SGLT2i significantly enhanced outcomes in HF, including a composite of hospitalizations for HF and cardiovascular death, individual hospitalizations for HF, Kansas City Cardiomyopathy Questionnaire (KCCQ) scores, left atrial volume index (LAVi), and LVEF among all HF patients (P
- Published
- 2024
- Full Text
- View/download PDF